nadifloxacin has been researched along with minocycline in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berger, MR; Galle, PR; Gockel, I; Graf, C; Herzog, J; Lang, H; Möhler, M; Schimanski, CC; Theobald, M; Wehler, TC | 1 |
Ghosh, S; Gupta, T; Kaur, SP; Sadhasivam, S; Saini, S; Sardana, K; Sengupta, S; Sinha, M | 1 |
2 other study(ies) available for nadifloxacin and minocycline
Article | Year |
---|---|
Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective.
Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Detergents; Exanthema; Fluoroquinolones; Gastrointestinal Neoplasms; Humans; Metronidazole; Minocycline; Prednisolone; Quinolizines; Retrospective Studies; Treatment Outcome; Vitamin K 1 | 2013 |
Heterogeneity and antibiotic resistance in Propionibacterium acnes isolates and its therapeutic implications: blurring the lines between commensal and pathogenic phylotypes.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Substitution; Drug Therapy, Combination; Fluoroquinolones; Genotype; Humans; Male; Minocycline; Phenotype; Phylogeny; Propionibacterium acnes; Quinolizines; Remission Induction; Ribotyping; Skin; Treatment Outcome; Young Adult | 2016 |